Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

October 19, 2015

Primary Completion Date

February 26, 2020

Study Completion Date

February 26, 2020

Conditions
Parkinson Disease (PD)
Trial Locations (13)

T2N 4Z6

University of Calgary /ID# 151948, Calgary

T6G 2X8

Zeidler Ledcor Centre /ID# 135979, Edmonton

R2H 2A5

St. Boniface Clinic, CA /ID# 162092, Winnipeg

L8L 2X2

Hamilton Health Sciences /ID# 148808, Hamilton

K7L 2V7

Kingston General Hospital /ID# 144942, Kingston

N6A 5A5

London Health Sciences Centre /ID# 138434, London

K1H 8L6

The Ottawa Hospital /ID# 135981, Ottawa

M5T 2S8

Toronto Western Hospital /ID# 135980, Toronto

H2X 0A9

CHUM - Notre-Dame Hospital /ID# 135977, Montreal

H3G 1A4

McGill Univ HC /ID# 138334, Montreal

G1J 1Z4

Ctr Hosp Enfant Jesus /ID# 138435, Québec

G6V 3Z1

CSSS Alphonse-Desjardins, CHAU de Levis /ID# 144941, Québec

J1H 5N4

CHUS - Hopital Fleurimont /ID# 148811, Sherbrooke

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY